Diamyd Medical AB Stock
Stocks
DMYD B
SE0005162880
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 1.040 SEK | +0.97% |
|
+0.58% | -90.76% |
| 07-27 | Diamyd Medical CEO buys shares for nearly 100,000 kronor | FW |
| 07-27 | Diamyd Medical AB Provides Update On Learnings From DIAGNODE-3 Interim Analysis | CI |
| Market Cap | 159M 16.6M 14.28M 13.43M 12.27M 22.95M 1.57B 23.04M 61.54M 804M 62.35M 60.96M 2.61B | P/E 2024 |
-10.2x | P/E 2025 | -7.49x |
|---|---|---|---|---|---|
| Enterprise Value | -118M -12.39M -10.66M -10.03M -9.16M -17.13M -1.17B -17.2M -45.95M -600M -46.55M -45.51M -1.95B | EV / Sales 2024 |
11,578x | EV / Sales 2025 | 9,820x |
| Free-Float |
83.81% | Yield 2024 * |
-
| Yield 2025 | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| DMYD B | Delayed | |
Deutsche Boerse AG
| DMN | Delayed | |
|
Boerse Muenchen
| DMN | Real-time |
Last Transcript : Diamyd Medical AB
| 1 day | +0.97% | ||
| 1 week | +0.58% | ||
| Current month | +1.56% | ||
| 1 month | -0.57% | ||
| 3 months | -7.31% | ||
| 6 months | -93.18% | ||
| Current year | -90.76% |
| 1 week | 1 |  | 1.06 |
| 1 month | 1 | | 1.09 |
| Current year | 0.9 | | 17.88 |
| 1 year | 0.9 | | 17.88 |
| 3 years | 0.9 | | 25 |
| 5 years | 0.9 | | 39.84 |
| 10 years | 0.9 | | 74.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 85 | 2026-04-23 | |
| Director of Finance/CFO | 53 | 2026-06-30 | |
Anton Lindqvist
CTO | Chief Tech/Sci/R&D Officer | 46 | 2012-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 85 | 2023-10-01 | |
| Director/Board Member | 56 | 2008-12-31 | |
| Chairman | 65 | 2026-04-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/27/25 | Don | Chief Executive Officer | 100,000 | 0.0791% | ||
| 5/5/25 | Buy | Chief Executive Officer | 1,000 | 0.0008% | ||
| 5/2/25 | Buy | 1,020 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.97% | +0.58% | -91.43% | -89.80% | 16.85M | |
| -1.79% | -2.27% | +43.23% | +88.96% | 67.98B | |
| -2.06% | -0.18% | +39.67% | +86.44% | 64.94B | |
| -0.31% | +6.54% | -12.96% | +378.92% | 27.58B | |
| +0.86% | +1.65% | -7.74% | -14.95% | 26.06B | |
| -3.00% | -2.90% | +33.13% | +12.54% | 25.74B | |
| -1.46% | +0.42% | +23.61% | -18.61% | 20.09B | |
| -2.96% | -15.21% | +216.20% | +368.10% | 17.16B | |
| -1.49% | -4.88% | -6.60% | +531.89% | 14.92B | |
| -0.20% | +8.37% | +55.78% | +164.98% | 14.62B | |
| Average | -1.14% | +0.29% | +29.29% | +150.85% | 27.91B | |
| Weighted average by Cap. | -1.52% | +0.18% | +38.37% | +137.33% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 130K 13.6K 11.7K 11K 10.05K 18.8K 1.29M 18.87K 50.41K 658K 51.08K 49.93K 2.14M | 130K 13.6K 11.7K 11K 10.05K 18.8K 1.29M 18.87K 50.41K 658K 51.08K 49.93K 2.14M |
| Net income | -152M -15.88M -13.67M -12.85M -11.74M -21.96M -1.5B -22.04M -58.89M -769M -59.66M -58.32M -2.5B | -170M -17.76M -15.28M -14.37M -13.13M -24.55M -1.68B -24.64M -65.84M -860M -66.7M -65.21M -2.79B |
| Net Debt | -132M -13.84M -11.91M -11.2M -10.23M -19.14M -1.31B -19.21M -51.33M -670M -52.01M -50.84M -2.18B | -277M -28.99M -24.95M -23.46M -21.43M -40.09M -2.74B -40.23M -107M -1.4B -109M -106M -4.56B |
Employees
44
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | SEK 1.040 | +0.97% | 247,358 |
| 26-09-03 | SEK 1.030 | -2.46% | 344,152 |
| 26-09-02 | SEK 1.056 | +3.53% | 303,341 |
| 26-09-01 | SEK 1.020 | -0.39% | 200,646 |
| 26-08-31 | SEK 1.024 | -0.97% | 278,080 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- DMYD B Stock
Select your edition
All financial news and data tailored to specific country editions
